Select a section from the left sidebar
Pentadecane
- Family: Plantae - Asteraceae
- Kingdom: Plantae
- Class: N-Alkane
Canonical Smiles | CCCCCCCCCCCCCCC |
---|---|
InChI | InChI=1S/C15H32/c1-3-5-7-9-11-13-15-14-12-10-8-6-4-2/h3-15H2,1-2H3 |
InChIKey | YCOZIPAWZNQLMR-UHFFFAOYSA-N |
Formula | C15H32 |
HBA | 0 |
HBD | 0 |
MW | 212.42 |
Rotatable Bonds | 12 |
TPSA | 0.0 |
LogP | 6.1 |
Number Rings | 0 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Fraction CSP3 | 1.0 |
Exact Mass | 212.25 |
Number of Lipinski Rule Violations | 1 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Senecio serratuloides | Asteraceae | Plantae | 2976806 |
Showing of synonyms
Pentadecane
N-PENTADECANE
629-62-9
Pentadekan
Pentadecane, n-
HSDB 5729
EINECS 211-098-1
NSC 172781
UNII-16H6K2S8M2
BRN 1698194
DTXSID6027268
CHEBI:28897
16H6K2S8M2
NSC-172781
DTXCID107268
EC 211-098-1
CH3-[CH2]13-CH3
4-01-00-00529 (Beilstein Handbook Reference)
CH3-(CH2)13-CH3
PENTADECANE (N)
UNII: 16H6K2S8M2
211-098-1
MFCD00008990
N-Pentadecane 100 microg/mL in Acetonitrile
Pentadecane, analytical standard
Pentadecan
Medicinal Plant
Pentadecane, >=99%
Ghl.PD_Mitscher_leg0.43
N-PENTADECANE [HSDB]
CH3(CH2)13CH3
CHEMBL1234557
Pentadecane_Ramanathan &Gurudeeban
Pentadecane, >=98.0% (GC)
HY-N7926
Tox21_300535
LMFA11000006
NSC172781
STL280516
AKOS015902386
NCGC00164185-01
NCGC00164185-02
NCGC00254392-01
CAS-629-62-9
LS-14458
CS-0138815
NS00003105
P0606
C08388
D97801
Q150831
896D4B7E-BF33-4D54-82CE-7360D88E8DC8
- Tata CM, Ndinteh D, et al. (2020). Fractionation and bioassay-guided isolation of antihypertensive components of Senecio serratuloides. Cogent Medicine,2020 , 7(1). [View]
Pubchem:
12391
Cas:
629-62-9
Gnps:
CCMSLIB00006411899
Zinc:
ZINC000001531089
Kegg Ligand:
C08388
Chebi:
28897
Nmrshiftdb2:
60018694
Metabolights:
MTBLC28897
Chembl:
CHEMBL1234557
Comptox:
DTXSID6027268
Pdb Ligand:
MYS
CPRiL:
79622
No scaffolds available.
Antihypertensive
Absorption
- Caco-2 (logPapp)
- -4.68
- Human Oral Bioavailability 20%
- Non-Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -3.75
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Substrate
- Skin Permeability
- -3.56
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 1.86
- Plasma Protein Binding
- 13.09
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Inhibitor
- CYP 1A2 Inhibitor
- Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Non-Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 6.84
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Safe
- Bioconcentration Factor
- 2.17
- Biodegradation
- Toxic
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Toxic
- Eye Irritation
- Toxic
- Maximum Tolerated Dose
- 1.64
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 4.7
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- 6.82
- Rat (Acute)
- 1.12
- Rat (Chronic Oral)
- 2.38
- Fathead Minnow
- 4.15
- Respiratory Disease
- Safe
- Skin Sensitisation
- Toxic
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 269.2
- Hydration Free Energy
- 2.75
- Log(D) at pH=7.4
- 5.79
- Log(P)
- 8.5
- Log S
- -7.61
- Log(Vapor Pressure)
- -2.14
- Melting Point
- 13.1
- pKa Acid
- 11.76
- pKa Basic
- 11.04
Protein Name | UniProt ID | Entry Name | Species | #Pharmacophore Points | Probability (0.7 ≤ Tversky Score ≤ 1.0) |
---|---|---|---|---|---|
Mycinamicin III 3''-O-methyltransferase | Q49492 | MYCF_MICGR | Micromonospora griseorubida | 2 | 0.8521 |
Acetylcholinesterase | P21836 | ACES_MOUSE | Mus musculus | 2 | 0.8072 |
3-ketosteroid dehydrogenase | Q9RA02 | Q9RA02_RHOER | Rhodococcus erythropolis | 2 | 0.8009 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | P04191 | AT2A1_RABIT | Oryctolagus cuniculus | 2 | 0.7930 |
Retinoic acid receptor RXR-alpha | P19793 | RXRA_HUMAN | Homo sapiens | 2 | 0.7919 |
Retinoic acid receptor RXR-alpha | P19793 | RXRA_HUMAN | Homo sapiens | 2 | 0.7899 |
Steroid Delta-isomerase | P00947 | SDIS_COMTE | Comamonas testosteroni | 2 | 0.7881 |
Peridinin-chlorophyll a protein, high-salt form | O76183 | O76183_AMPCA | Amphidinium carterae | 2 | 0.7857 |
Beta-1 adrenergic receptor | P07700 | ADRB1_MELGA | Meleagris gallopavo | 2 | 0.7808 |
Beta-1 adrenergic receptor | P07700 | ADRB1_MELGA | Meleagris gallopavo | 2 | 0.7789 |
Sodium-dependent dopamine transporter | Q7K4Y6 | DAT_DROME | Drosophila melanogaster | 2 | 0.7756 |
Cellular retinoic acid-binding protein 2 | P29373 | RABP2_HUMAN | Homo sapiens | 2 | 0.7680 |
Steroid C26-monooxygenase | P9WPP1 | CP125_MYCTU | Mycobacterium tuberculosis | 2 | 0.7664 |
Aldo-keto reductase family 1 member C3 | P42330 | AK1C3_HUMAN | Homo sapiens | 2 | 0.7641 |
Albumin | P02768 | ALBU_HUMAN | Homo sapiens | 2 | 0.7558 |
Beta-1 adrenergic receptor | P07700 | ADRB1_MELGA | Meleagris gallopavo | 2 | 0.7547 |
Peroxisome proliferator-activated receptor gamma | P37231 | PPARG_HUMAN | Homo sapiens | 2 | 0.7435 |
4,4'-diapophytoene synthase | A9JQL9 | CRTM_STAAU | Staphylococcus aureus | 2 | 0.7321 |
Methylketone synthase I | E0YCS2 | E0YCS2_SOLHA | Solanum habrochaites | 2 | 0.7204 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | P04191 | AT2A1_RABIT | Oryctolagus cuniculus | 2 | 0.7151 |
Gastrotropin | P51161 | FABP6_HUMAN | Homo sapiens | 2 | 0.7027 |